Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.
New mRNA vaccine is more effective and less costly to develop. A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a ...
Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results